Ohio State University Medical Center to Test Efficacy of Hyperbaric Oxygen Medicine...

Ohio State University Medical Center to Test Efficacy of Hyperbaric Oxygen
Medicine on Stroke Victims

ANAHEIM, Calif., May 20 /PRNewswire/ -- With the financial support of
Sechrist Industries, Inc., The Center for Minimally Invasive Surgery (CMIS) at
the Ohio State University Medical Center has begun testing the efficacy of
hyperbaric oxygen medicine on experimental stroke models. CMIS is a
multidisciplinary center dedicated to excellence in patient care, clinical
training, research and outcomes studies pertaining to the techniques and
technology of minimally invasive surgery.
Currently utilized for the treatment of chronic, non-healing wounds,
carbon monoxide poisoning, crush injuries as well as other indications, the
use of hyperbaric medicine for stroke victims is at the forefront of
hyperbaric research. Hyperbaric oxygen therapy is the treatment of the entire
body with 100-percent oxygen at greater than normal atmospheric pressures.
Hyperbaric medicine greatly increases oxygen concentration in all body
tissues, even with reduced or blocked blood flow, stimulates the growth of new
blood vessels to locations with reduced circulation (improving blood flow to
areas with arterial blockage) and causes a rebound arterial dilation after
treatment, resulting in an increased blood vessel diameter greater than when
therapy began, thus improving blood flow to compromised organs. The CMIS team
is hopeful that these benefits of hyperbaric oxygen treatments will positively
affect stroke patients.
"Ohio State University Medical Center is one of the finest health care
institutions in the country," stated Jack Rollins, President and CEO of
Sechrist Industries, Inc. "As the world leader in hyperbaric oxygen
technology, we feel that it is important to join forces with CMIS to support
research in the field of hyperbaric medicine."
"We believe that there is a window of opportunity to treat stroke related
injury of the brain using hyperbaric oxygen. The challenge lies in accurately
defining the perimeters of that window," says Chandan Sen, Director of the
Comprehensive Wound Center at the Ohio State University Medical Center.
For additional information, contact Monica Gutierrez
(mgutierrez@sechristusa.com) or visit http://www.sechristusa.com.
ABOUT Sechrist Industries -- Sechrist is the leading manufacturer of
monoplace HBO chambers in the USA, and supplies more monoplace chambers than
all other manufacturers combined with over 2000 installed around the world.
SOURCE Sechrist Industries, Inc.

Monica Gutierrez of Sechrist Industries, Inc., 1-800-SECHRIST (732-4747), fax,
+1-714-579-0814, mgutierrez@sechristusa.com